RecruitingVaccination; Infection
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
Eligible age
18–100 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Immune response to influenza vaccine in patients with chronic renal insufficiency.
Sponsor: Centre Hospitalier Universitaire de Nice
You may qualify if…
- ✓ Chronic renal failure patient at stage 4 or 5 (i.e. estimated GFR \< 30mL/min/1.73m2); or Dialysis patient; or renal transplant patient regardless of GFR;
- ✓ Age ≥ 18 years;
- ✓ Indication for influenza vaccination;
- ✓ Express free and informed consent.
You may not qualify if…
- ✕ Known hypersensitivity to influenza vaccine or egg proteins;
- ✕ Previous influenza vaccination for the current season;
- ✕ Current infection;
- ✕ Current acute illness;
- ✕ Treatments with a major impact on vaccine response:
- ✕ Treatment of rejection within the previous 3 months;
- ✕ Renal transplantation with induction performed within the previous 6 months;
- ✕ Immunosuppressive treatment including CTLA4 agonist, complement inhibitor, anti-CD20;
Source: ClinicalTrials.gov · NCT06907667 · last updated 2026-05-15